# Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial Injury

> **NCT05399576** · PHASE2 · UNKNOWN · sponsor: **The First Affiliated Hospital of Zhejiang Chinese Medical University** · enrollment: 150 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Nicorandil
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05399576
- **Lead sponsor:** The First Affiliated Hospital of Zhejiang Chinese Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-17
- **Primary completion:** 2023-05-17
- **Final completion:** 2023-09-17
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05399576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05399576, "Intracoronary of Nicorandil and Verapamil to Reduce the Occurrence of Periprocedural Myocardial Injury". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05399576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*